HK Stock Market Move | MICROPORT NEURO (02172) surged over 5% in early trading. MICROPORT terminates merger with MICROPORT NEURO, accelerating commercialization of brain-machine interfaces.

date
09:33 02/01/2026
avatar
GMT Eight
Minimally Invasive Brain Science (02172) surged more than 5% in early trading, as of the time of writing, it was up 3.03% at HK$11.21, with a turnover of HK$1.5032 million.
MICROPORT NEURO (02172) rose more than 5% in the morning session, and as of the time of writing, it had risen by 3.03% to HK$11.21, with a trading volume of HK$1.5032 million. On the news front, MICROPORT announced the termination of the merger with MICROPORT NEURO. The reason is that after appointing an independent non-executive director, the company believed it could not control MICROPORT NEURO according to accounting policies but still maintained significant influence. The termination of the merger is expected to confirm the recognition of disposal income from subsidiaries. In addition, Musk recently stated that his brain-machine interface company Neuralink will start mass production of brain-machine interface devices in 2026 and simultaneously advance the full automation of the surgical process. Guotai Haitong pointed out that with technological breakthroughs, policy support, and capital investment driving factors, the brain-machine interface industry is expected to embrace significant development opportunities and may witness demand releases in downstream markets such as medical health and lifestyle consumption. The market outlook is promising. (Note: This translation may include some investment or financial terminology that may not be common in everyday language.)